Blog
RSS FeedPosted by Michael Wonder on 14 Mar 2019
Statement by FDA Commissioner on new strategies to modernise clinical trials to advance precision medicine, patient protections and more efficient product development
14 March 2019 - Modernizing clinical trials is an agency wide priority. ...
Posted by Michael Wonder on 13 Mar 2019
FDA medical adviser: 'Congress is owned by pharma'
13 March 2019 - Pharmaceutical companies are under the spotlight with congressional hearings on the cost of drug prices and ...
Posted by Michael Wonder on 04 Mar 2019
Drug companies and doctors battle over the future of faecal transplants
3 March 2019 - As pharmaceutical companies seek to profit from the curative wonders of human faeces, doctors worry about new ...
Posted by Michael Wonder on 26 Feb 2019
Former Novartis executive wins $1.5 million after claiming she was fired for complaining about a study
26 February 2019 - Min Amy Guo, who had been executive director of the Health Economics and Outcomes Research Group, objected ...
Posted by Michael Wonder on 21 Feb 2019
The fighter, the saint, and the odd man out: the executives who will defend pharma before Congress
21 February 2019 - One’s a college dropout. One’s a self-proclaimed street fighter. And one survived a presidential tweetstorm. ...
Posted by Michael Wonder on 23 Jan 2019
Modernising clinical trials for patients with cancer
23 January 2019 - Clinical trials involve evaluating and validating new therapies in humans and represent the fundamental means of making ...
Posted by Michael Wonder on 22 Jan 2019
Celgene, sold for $74 billion, leaves a legacy of chutzpah in science and drug pricing
22 January 2019 - Nina Kjellson was just two years out of college, working as a research associate at Oracle ...
Posted by Michael Wonder on 14 Jan 2019
Why pharmaceutical companies are on a shopping binge
14 January 2019 - With the cost of R&D so high, it may make sense to spend money on a competitor. ...
Posted by Michael Wonder on 12 Dec 2018
FDA takes aim at pharma’s biosimilar-delaying tactics
12 December 2018 - Ever-rising cost of insulins also to be targeted. ...
Posted by Michael Wonder on 11 Dec 2018
The drug industry is headed back to Congress to make its case. Will Democrats keep the door open?
10 December 2018 - With annual revenues of roughly $450 million and an army of some 160 lobbyists, PhRMA has ...
Posted by Michael Wonder on 08 Dec 2018
Patent abuse is driving up drug prices. Just look at Lantus.
7 December 2018 - A rare point of consensus following the midterm elections is that Americans are adamant about lowering ...
Posted by Michael Wonder on 06 Dec 2018
FDA publishes post CRL guidance for generic companies
4 December 2018 - The US FDA has published final guidance for the generics industry on post-complete response letter meetings. ...
Posted by Michael Wonder on 15 Nov 2018
Disclosing prescription-drug prices in advertisements — legal and public health issues
14 November 2018 - On October 15, 2018, the CMS proposed a rule requiring television advertisements for prescription drugs and ...
Posted by Michael Wonder on 09 Nov 2018
Lilly snaps up regulatory 'fast pass' for bargain price
2 November 2018 - Priority review vouchers used to be highly sought: back in 2015, for example, AbbVie paid United ...
Posted by Michael Wonder on 25 Oct 2018
Pharmaceutical industry challenges Trump plan forcing companies to reveal drug prices in TV ads
25 October 2018 - Symbicort, an inhaler marketed to people whose lung disease makes them “huff and puff,” rolls off ...